Cite
MLA Citation
Sandra McCurdy et al.. “Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial.” International journal of infectious diseases, vol. 97, 2020, pp. 374–379. http://access.bl.uk/ark:/81055/vdc_100105279736.0x00001e